| scholarly article | Q13442814 |
| P50 | author | Ernesto Martinez-Martinez | Q42364398 |
| P2093 | author name string | Frederic Jaisser | |
| Antoine Ouvrard-Pascaud | |||
| Alexandre Gueret | |||
| Amaya Fernández-Celis | |||
| Jaime Ibarrola | |||
| Natalia López-Andrés | |||
| Paul Mulder | |||
| Jean-Paul Henry | |||
| Lionel Nicol | |||
| Lara Matilla | |||
| P2860 | cites work | Galectin-3 is essential for early wound healing and ventricular remodeling after myocardial infarction in mice | Q58023142 |
| Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis | Q61187743 | ||
| Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction | Q86135613 | ||
| A role for fumarate hydratase in mediating oxidative effects of galectin-3 in human cardiac fibroblasts | Q88071761 | ||
| Modified citrus pectin anti-metastatic properties: one bullet, multiple targets | Q24651188 | ||
| Galectin-3 mediates post-ischemic tissue remodeling | Q28578907 | ||
| Myocardial perfusion imaging using a non-contrast agent MR imaging technique. | Q30660661 | ||
| Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis | Q34316944 | ||
| Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction | Q34364121 | ||
| Myocardial ischemia-reperfusion injury: a neglected therapeutic target. | Q36497176 | ||
| Myocardial Galectin-3 Expression Is Associated with Remodeling of the Pressure-Overloaded Heart and May Delay the Hypertrophic Response without Affecting Survival, Dysfunction, and Cardiac Fibrosis. | Q36885706 | ||
| Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy | Q37774078 | ||
| Role of the carboxyl-terminal lectin domain in self-association of galectin-3. | Q38338168 | ||
| Growth differentiation factor 15 acts anti-apoptotic and pro-hypertrophic in adult cardiomyocytes | Q38345677 | ||
| Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension | Q38387964 | ||
| Galectin-3 and cardiac function in survivors of acute myocardial infarction. | Q38454450 | ||
| Galectin-3 and post-myocardial infarction cardiac remodeling. | Q38534975 | ||
| Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction | Q38820409 | ||
| Galectin-3 and sST2 in prediction of left ventricular ejection fraction after myocardial infarction | Q40362335 | ||
| Neutrophil Gelatinase-Associated Lipocalin, a Novel Mineralocorticoid Biotarget, Mediates Vascular Profibrotic Effects of Mineralocorticoids. | Q40925536 | ||
| The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries. | Q41744993 | ||
| Differential Proteomics Identifies Reticulocalbin-3 as a Novel Negative Mediator of Collagen Production in Human Cardiac Fibroblasts | Q42362900 | ||
| Ischemic preconditioning protects against coronary endothelial dysfunction induced by ischemia and reperfusion | Q42498640 | ||
| Myocardial blood flow mapping in mice using high-resolution spin labeling magnetic resonance imaging: influence of ketamine/xylazine and isoflurane anesthesia. | Q45276571 | ||
| A Role for galectin-3 in renal tissue damage triggered by ischemia and reperfusion injury | Q46461255 | ||
| Utility of galectin-3 in predicting post-infarct remodeling after acute myocardial infarction based on extracellular volume fraction mapping. | Q50230482 | ||
| Enhanced angiogenesis and increased cardiac perfusion after myocardial infarction in protein tyrosine phosphatase 1B-deficient mice. | Q53055910 | ||
| Galectin-3 is expressed in the myocardium very early post-myocardial infarction. | Q53651562 | ||
| Myocardial Ischemia Reperfusion Injury: Apoptotic, Inflammatory and Oxidative Stress Role of Galectin-3 | Q57790567 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 9607 | |
| P577 | publication date | 2019-07-03 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition | |
| P478 | volume | 9 |
| Q92277516 | Biomarkers of Inflammation and Fibrosis in Kawasaki Disease Patients Years After Initial Presentation With Low Ejection Fraction |
| Q100559778 | Elevated perfusate [Na+] increases contractile dysfunction during ischemia and reperfusion |
Search more.